Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Riñones
33
Enfermedades
24
Enfermería
13
Fisiología
8
Insuficiencia renal
7
Insuficiencia renal crónica
6
Nutrición
5
Tratamiento
5
Aparato urinario
4
Dietoterapia
4
Diálisis
4
Nefrología
4
Química clínica
4
Trasplantes de riñones
4
Diagnóstico
3
Licenciado en Enfermería
3
Aspectos nutricionales
2
Atención al paciente
2
Atlas
2
Cirugía
2
Dieta para enfermos
2
Farmacología
2
Farmacología clínica
2
Fisiología renalAparato urinario
2
Fisiopatología
2
Fisiopatología de riñones
2
Hemodiálisis
2
Medicina
2
Medicina clínica
2
Urología pediátrica
2
-
101801por González, Jessica, de Batlle, Jordi, Benítez, Iván D., Torres, Gerard, Santisteve, Sally, Targa, Adriano D.S., Gort-Paniello, Clara, Moncusí-Moix, Anna, Aguilà, Maria, Seck, Fatty, Ceccato, Adrián, Ferrer, Ricard, Motos, Anna, Riera, Jordi, Fernández, Laia, Menéndez, Rosario, Lorente, José Ángel, Peñuelas, Oscar, Garcia-Gasulla, Dario, Peñasco, Yhivian, Ricart, Pilar, Abril Palomares, Elena, Aguilera, Luciano, Rodríguez, Alejandro, Boado Varela, Maria Victoria, Beteré, Belén, Pozo-Laderas, Juan Carlos, Solé-Violan, Jordi, Salvador-Adell, Inmaculada, Novo, Mariana Andrea, Barberán, José, Amaya Villar, Rosario, Garnacho-Montero, José, Gómez, José M., Blandino Ortiz, Aaron, Tamayo Lomas, Luis, Úbeda, Alejandro, Catalán-González, Mercedes, Sánchez-Miralles, Angel, Martínez Varela, Ignacio, Jorge García, Ruth Noemí, Franco, Nieves, Gumucio-Sanguino, Víctor D., Bustamante-Munguira, Elena, Valdivia, Luis Jorge, Caballero, Jesús, Gallego, Elena, Rodríguez, Covadonga, Castellanos-Ortega, Álvaro, Trenado, Josep, Marin-Corral, Judith, Albaiceta, Guillermo M., de la Torre, Maria del Carmen, Loza-Vázquez, Ana, Vidal, Pablo, Añón, Jose M., Carbajales Pérez, Cristina, Sagredo, Victor, Carbonell, Nieves, Socias, Lorenzo, Barberà, Carme, Estella, Angel, Diaz, Emili, de Gonzalo-Calvo, David, Torres, Antoni, Barbé, Ferran“…CONCLUSION: Age and CLD, reflecting patients’ baseline vulnerability, and markers of COVID-19 severity, such as duration of IMV and renal failure, were key factors associated with impaired D(LCO) and CT abnormalities.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101802“…Les antécédents les plus fréquents étaient l’hypertension artérielle (71,4 %), diabète (21,8 %) et insuffisance rénal (7,1 %). La pathologie néoplasique prédominante était le cancer pulmonaire (n = 5), suivi par le cancer du sein (n = 3), cancer du colon (n = 2), cancer cavum (n = 1), colon (n = 1), estomac (n = 1) et cancer du prostate (n = 1). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101803por Xu, Xuan, Tian, Wende, Duan, Wenhui, Pan, Chaoxin, Huang, Mingjian, Wang, Qinggao, Yang, Qinghua, Wen, Zhihao, Tang, Yu, Xiong, Yao, Zhu, Zhiyun, Liu, Yuanyuan, Wei, Dan, Qi, Wenqiang, Ouyang, Xiaochao, Ying, Shaozhen, Wang, Xiaohua, Zhou, Zhigang, Li, Xiaofeng, Cui, Yu, Yang, Shuyin, Xu, Hao“…No abnormal vital signs (except BP) or severe liver or renal function impairment were observed during the treatment periods; in addition, adverse events and drug reactions were mild. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101804por Witte, Klaus K., Wachter, Rolf, Senni, Michele, Belohlavek, Jan, Straburzynska‐Migaj, Ewa, Fonseca, Candida, Lonn, Eva, Noè, Adele, Schwende, Heike, Butylin, Dmytro, Chiang, YannTong, Pascual‐Figal, Domingo“…At 10 weeks, hypotension and renal dysfunction rates were similar, although hyperkalaemia was higher among patients with diabetes (15.9% vs. 9.5%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101805por Ma, Yanqi, Zhou, Qikai, Zhao, Pingping, Lv, Xiaoyu, Gong, Caixia, Gao, Jie, Liu, Jingfang“…Moreover, the effect of AGE-Tf on human renal tubular epithelial cells (HK-2) was investigated. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101806“…Lors des analyses stratifiées par type de cancer, on observait un risque significativement plus élevé de diagnostic de cancer rénal (aHR 3,16, IC 95% 2,33-4,27), de cancers hématologiques (aHR 2,54, IC 95% 2,07-3,12), de cancer du côlon (aHR 1,72, IC 95% 1,34-2,21) et de cancer pulmonaire (aHR 1,70, IC 95% 1,39-2,08). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101807por Janapala, Rajesh naldu, jayaraj, joseph, Rass, bayan, Zarghamravanbakhsh, Paria, Sachmechi, issac“…Other common side effects of amphotericin B are renal toxicities, hepatic toxicities and electrolyte imbalances, mainly Hypokalemia and Hypomagnesemia. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101808por Reber, Josefine Astrid“…To improve this situation, we aimed to develop and evaluate strategies for the performance of FR-targeted radionuclide therapy by decreasing the renal uptake of radiofolates and thereby reducing potential nephrotoxic effects. …”
Publicado 2015
Enlace del recurso
-
101809por Raynaud, Marc, Al-Awadhi, Solaf, Juric, Ivana, Divard, Gillian, Lombardi, Yannis, Basic-Jukic, Nikolina, Aubert, Olivier, Dubourg, Laurence, Masson, Ingrid, Mariat, Christophe, Prié, Dominique, Pernin, Vincent, Le Quintrec, Moglie, Larson, Timothy S, Stegall, Mark D, Bikbov, Boris, Ruggenenti, Piero, Mesnard, Laurent, Ibrahim, Hassan N, Nielsen, Marie Bodilsen, Matas, Arthur J, Nankivell, Brian J, Benjamens, Stan, Pol, Robert A, Bakker, Stephan J L, Jouven, Xavier, Legendre, Christophe, Kamar, Nassim, Smith, Byron H, Wadei, Hani M, Durrbach, Antoine, Vincenti, Flavio, Remuzzi, Giuseppe, Lefaucheur, Carmen, Bentall, Andrew J, Loupy, Alexandre“…The race-free equation, based on creatinine level, age, and sex, was developed using additive and multiplicative linear regressions, and its performance was compared with the three current main GFR equations: Modification of Diet in Renal Disease (MDRD) equation, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 equation, and race-free CKD-EPI 2021 equation. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101810por Ren, Yuechang, Zhao, Tianyu, Zhang, Kaiying, Zhu, Zhengqi, Li, Linkui, Li, Yang, Jiang, Shuzhen, Jiao, Ning, Yang, Weiren“…The results indicated that both renal P reabsorption and bone resorption were involved in adapting to a low-P diet. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101811por Kataria, Sahil, Singh, Omender, Juneja, Deven, Goel, Amit, Bhide, Madhura, Yadav, Devraj“…RESULTS: Patient demographics, comorbidities, baseline laboratory, vital parameters, source of infection, baseline lactate levels, and lactate clearance at 3 h and 6 h, Sequential Organ Failure scores, need for invasive mechanical ventilation, days on mechanical ventilation, and renal replacement therapy-free days within 28 d, duration of intensive care unit stay, and hospital stay were comparable between the two groups. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101812por MacLean, Elizabeth, Cisar, Laura, Mehle, Kimberly, Eremina, Daria, Quigley, Jane M.“…BACKGROUND: Axitinib is approved by the FDA for the treatment of advanced renal cell carcinoma (RCC) after failure of 1 previous systemic therapy and is distributed primarily through specialty pharmacies. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101813por Laliberte, Francois, Bookhart, Brahim K., Vekeman, Francis, Corral, Mitra, Duh, Mei Sheng, Bailey, Robert A., Piech, Catherine Tak, Lefebvre, Patrick“…BACKGROUND: Diabetes and hypertension are the 2 major causes of endstage renal disease. The rate of chronic kidney disease (CKD) secondary to diabetes and/or hypertension is on the rise, and the related health care costs represent a significant economic burden. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101814HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysispor Palmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David W., Perkovic, Vlado, Hegbrant, Jorgen, Strippoli, Giovanni F. M.“…METHODS: Search methods: We searched the Cochrane Renal Group's Specialised Register to 5 June 2012 through contact with the Trials' Search Co-ordinator using search terms relevant to this review. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101815HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysispor Palmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David D., Perkovic, Vlado, Hegbrant, Jorgen, Strippoli, Giovanni F. M.“…METHODS: Search methods: We searched the Cochrane Renal Group's Specialised Register to 5 June 2012 through contact with the Trials' Search Co-ordinator using search terms relevant to this review. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101816por Katwal, Dilasha, Pokharel, Yasmina, Ghawji, Maher, Liu, Zhao, Steinberg, Helmut O, Dagogo-Jack, Samuel“…Introduction: Sodium-Glucose Cotransporter Inhibitors (SGLT2i) treatment is increasing partly due to its cardiovascular and renal benefits, enlarging the population at-risk for euglycemic diabetic ketoacidosis (euDKA), a potentially life-threatening adverse event associated with SGLT2i use. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101817por Papadimitriou, Dimitrios T, Dermitzaki, Eleni, Christopoulos, Panagiotis, Papagianni, Maria, Kleanthous, Kleanthis, Marakaki, Chrysanthi, Papadimitriou, Anastasios, Mastorakos, George“…Serum T1Ab levels and fasting plasma glucose, HbA1c, c-peptide, Ca (tolerated ≤11.5 mg/dl), P, ALP, Ca/Cr 2-hr urine morning sample, 25(OH)D, 1-25(OH)2D with renal ultrasound in cases with hypercalcemia/hypercalciuria (tolerated ≤50%, or at the upper normal for age) were determined before and q3-6 months after initiation of calcitriol (0.05 mcg/Kg/day) 0.25-0.5 x 1-3/day or its synthetic analogue, paricalcitol (thrice the calcitriol dose) 1-4 mcg x 1-3/day p.o. under cholecalciferol repletion. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101818por Figueres, Lucile, Takacs, Istvan, Mezosi, Emese, Soto, Alfonso, Kamenicky, Peter, Lemoine, Sandrine, Borson-Chazot, Francoise, Capel, Ismael, Angeles Artazcoz Galvez Moreno, Maria Angeles, Ovize, Michel, OuldRouis, Taha, Allas, Soraya, Sumeray, Mark, Mannstadt, Michael“…Background: Conventional therapy with oral calcium (Ca) and active vitamin D (vitD) supplementation for chronic hypoparathyroidism (cHP) can induce or aggravate hypercalciuria and may lead to detrimental long-term renal complications. AZP-3601 is a novel 36-amino-acid peptide designed to activate the R(0) conformation of the PTH 1 receptor which produces a prolonged calcemic response despite a short half-life. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101819Publicado 2023“…In this study, we analyzed the relationship between serum VitD metabolites and renal impairment in patients with diabetic kidney disease (DKD). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101820“…RESULTS: The results of pan-cancer analysis and differential analysis collectively showed that except for renal clear cell carcinoma, the expression of lncRNA miR143HG in other cancer tissues was higher than that in healthy tissues, and the differences were significant in LUSC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto